EduBourseActualitésThe Assign Group Selects Oracle® Health Sciences Applications to Support Expansion Strategy

The Assign Group Selects Oracle® Health Sciences Applications to Support Expansion Strategy

Full-Service, Europe-based Contract Research Organization to Standardize Clinical Trial and Clinical Data Management on Oracle Health Sciences Platform
Redwood Shores, CA – October 21, 2009
News Facts
The Assign Group, a contact research organization that provides clinical trial and clinical trial data management through a network of affiliates in Europe and South America, is standardizing on Oracle® Health Sciences applications to gain scalability and robust functionality and streamline IT vendor management by selecting a single source for clinical applications across the group.
Assign Data Management & Biostatistics GmbH, the group’s affiliate that specializes in clinical trial data management, biostatistics and pharmacovigilance, has selected Oracle Clinical, Oracle Remote Data Capture, Oracle Adverse Event Reporting System and Oracle Thesaurus Management System as the foundation for a robust and standards-based clinical data management infrastructure that will support higher data volumes and an increased number of trials conducted in a broad range of clinical settings. The applications also will facilitate data export.
In addition, the group’s affiliates responsible for managing clinical trial processes are migrating to Oracle’s Siebel Clinical Trial Management System to enable greater visibility and management efficiency.
The Assign Group wanted an industry-proven, commercial off-the-shelf (COTS) solution that would further credential the organization in the market and enable it to focus resources on its core business, instead of on building and maintaining complex IT systems to support business processes across all affiliates.
The company plans to go live with all applications later this year. It is working with Triumph Consulting and Pharmasol, both Oracle Certified Partners, and is using Pharmasol RapidLive – an Oracle Accelerate solution that provides ready-to-use and validated implementations of Oracle Health Sciences applications – to accelerate the deployment cycle.
Supporting Quotes
“Oracle’s Siebel Clinical Trial Management System, Oracle Clinical and Oracle Remote Data Capture Onsite deliver powerful functionality and the scalability we require to grow our business. As important, they are industry-proven and respected solutions that will provide us with a key selling point in our discussions with potential clients,” said Dr. Anton Klingler, General Manager, Assign Data Management & Biostatistics GmbH.
“Health sciences organizations, like The Assign Group, are increasingly looking to IT solutions to help streamline clinical data management and improve efficiency throughout the clinical trial process,” said Neil de Crescenzo, Senior Vice President and General Manager, Oracle Health Sciences. “Oracle delivers a comprehensive suite of clinical IT applications with unmatched functionality – enabling organizations to address complex business challenges and accelerate insights for better health.”

Supporting Resources
About The Assign Group
Market Research Firm Cites Oracle as Top Software Vendor for the Life Sciences Industry
Follow Oracle Health Sciences on Twitter
Join the Oracle Health Sciences Community on Facebook
Oracle in Health Sciences
About Oracle
Oracle (NASDAQ: ORCL) is the world’s largest business software company. For more information about Oracle, please visit our Web site at

Oracle is a registered trademark of Oracle Corporation and/or its affiliates. Other names may be trademarks of their respective owners.
Contact Info
Kevin Ruane
[email protected]

Pierre Perrin-Monlouis
Pierre Perrin-Monlouis
Fondateur de Rente et Patrimoine (cabinet de gestion de patrimoine), Pierre Perrin-Monlouis est un analyste et trader pour compte propre. Il vous fait profiter de son expérience en trading grâce à ses analyses financières et décrypte pour vous les actualités des marchés. Son approche globale des marchés combine à la fois l'analyse technique et l'analyse fondamentale sur l'ensemble des marchés : crypto, forex, actions et matières premières.